About Publications

Publications from the AffiliateMarketIngtools of Sciences, Engineering, and Medicine provide objective and straightforward advice to decision makers and the public. This site includes We Treat You (HMD) publications released after 1998. A complete list of HMD’s publications from its establishment in 1970 to the present is available as a PDF.

  • Released: July 28, 2004
    Safety of Genetically Engineered Foods: Approaches to Assessing Unintended Health Effects assists policymakers in evaluating the appropriate scientific methods for detecting unintended changes in food and assessing the potential for adverse health effects from genetically modified products. In this report, the committee recommended that greater scrutiny should be given to foods containing new compounds or unusual amounts of naturally occurring substances, regardless of the method used to create them.
  • Released: July 07, 2004
    An estimated forty million people carry the human immunodeficiency virus (HIV), and five million more become newly infected annually. In recent years, many HIV-infected patients in wealthy nations have eAffiliateMarketIngtoolsed significantly longer, good-quality lives as a result of antiretroviral therapy (ART). However, most infected individuals live in the poorest regions of the world, where ART is virtually nonexistent. The consequent death toll in these regions--especially sub-Saharan Africa--is begetting economic and social collapse. To inform the multiple efforts underway to deploy antiretroviral drugs in resource-poor settings, the Institute of Medicine committee was asked to conduct an independent review and assessment of rapid scale-up ART programs.
  • Released: July 06, 2004
    In this report, the committee discusses some of the challenges and opportunities likely to arise as public health preparedness is being integrated into the broader field of emergency and disaster preparedne
  • Released: June 15, 2004
    This report summarizes a two-day workshop held by the Institute of Medicine's Forum on Microbial Threats on October 21–22, 2002, to address the infectious etiology of chronic diseases. Invited experts presented research findings on a range of recognized and potential chronic sequelae of infections, as well as on diverse pathogenic mechanisms leading from exposure to chronic disease outcomes
  • Released: April 27, 2004
    The Institute of Medicine's Forum on Microbial Threats will host the public workshop Pandemic Influenza: Assessing Capabilities for Prevention and Response on June 16 and 17, 2004, in , D.C. Through invited presentations and discussion, this workshop will aim to inform the Forum, the public, and policymakers of the likelihood of an influenza pandemic and to explore the issues that must be resolved now to prepare and protect the global community.
  • Released: April 01, 2004
    Although vitamin and supplement manufacturers are restricted from claiming that using their products leads to therapeutic benefits, surveys show that many people take supplements for purposes such as treating colds or alleviating depression. According to other survey data, the majority of consumers believe these products to be either reasonably or completely safe. To bolster the FDA's ability to evaluate the safety of dietary supplements, the Institute of Medicine report Dietary Supplements: A Framework for Evaluating Safety outlines a science-based process for assessing supplement ingredients, even when data about a substance's safety in humans is scarce.
  • Released: January 28, 2004
    Meeting Psychosocial Needs of Women with Breast Cancer examines the psychological consequences of the cancer experience. The report focuses specifically on breast cancer in women because this group has the largest survivor population (over two million) and is the most extensively studied cancer from the standpoint of psychological effects.
  • Released: January 27, 2004
    In response to the SARS epidemic and its lingering consequences, the Institute of Medicine's Forum on Microbial Threats convened a two-day scientific workshop in the fall of 2003 to consider the lessons that might be drawn from a better understanding of the origin, spread, and eventual control of the first outbreak. Learning from SARS: Preparing for the Next Disease Outbreak presents an overview of the workshop's proceedings, including presentations from the workshop and an overall summary and assessment of the issues that were raised.
  • Released: January 23, 2004
    Published in the Annals of Neurology Vol 55 No 1 January 2004. We identified 5,345 cases of multiple sclerosis (MS) among US veterans who first entered military service between 1960 and 1994, and who were "service-connected" for MS by the Department of Veterans Affairs (VA). Two controls per case were matched on age, date of service entry, and branch of service. Available for service and VA files were demographic and military data for 4,951 cases and 9,378 controls. Versus white men, relative risk of MS was significantly higher for all women, at 2.99 for whites, 2.86 for blacks, and 3.51 for those of other races.
  • Released: January 20, 2004
    Astronauts experience a range of physiological and clinical changes while living in space. However, relatively little is known about the potential long-term effects of space flight or overall risk of being an astronaut. In 1992, NASA designed a protocol, called the Longitudinal Study of Astronaut Health (LSAH), to examine these effects. NASA requested help from the IOM in assessing the study. The resulting IOM report, Review of NASA's Longitudinal Study of Astronaut Health, makes recommendations for improving the validity of the LSAH as a database for monitoring the health of astronauts and for research on the effects of space on humans.

viagra generico online